Fellowship · Washington, DC
Sponsored by George Washington University School of Medicine
T-cell Responses to Individualized Neoantigen Therapy mRNA-4157 (V940) Alone or in Combination with Pembrolizumab in the Phase 1 KEYNOTE-603 Study.
Cancer discovery · 2024 · 86 citations · Julie Bauman
Immunotherapy and Biomarker Testing in Recurrent and Metastatic Head and Neck Cancers: ASCO Guideline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 88 citations · Julie Bauman
Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors.
Nature medicine · 2021 · 180 citations · Pavani Dome
Radiotherapy with cetuximab or durvalumab for locoregionally advanced head and neck cancer in patients with a contraindication to cisplatin (NRG-HN004): an open-label, multicentre, parallel-group, randomised, phase 2/3 trial.
The Lancet. Oncology · 2024 · 60 citations · Julie Bauman
Randomized Phase II Study of Concurrent Versus Sequential Pembrolizumab in Combination With Chemoradiation in Locally Advanced Head and Neck Cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 27 citations · Julie Bauman
Differences in Cancer Phenotypes Among Frequent CHEK2 Variants and Implications for Clinical Care-Checking CHEK2.
JAMA oncology · 2022 · 80 citations ·
Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines.
Blood · 2021 · 114 citations · Charles Hesdorffer
Author Correction: Head and neck squamous cell carcinoma.
Nature reviews. Disease primers · 2023 · 42 citations · Julie Bauman